Holen Sie sich die Stockscreener-App
12.63
8.25%
-1.145
Jatt Ii Acquisition Corp Aktie (JATT) Neueste Nachrichten
Balyasny Asset Management L.P. Initiates Position in JATT II Acq - GuruFocus
ADAR1 Capital Management (JATT) discloses 5.4% beneficial stake in JATT II - Stock Titan
JATT II Acquisition Corp. (JATT) investors file update showing 0% stake - Stock Titan
JATT II Acquisition Corp (JATT) reports 6.23% stake held by Great Point - Stock Titan
Atika Capital (JATT) discloses 5.1% beneficial stake in JATT II Acquisition Corp. - Stock Titan
Balyasny Asset Management (JATT) discloses 6.23% holding in JATT II common stock - Stock Titan
Janus Henderson Group (JATT) discloses 6.2% beneficial stake in JATT II - Stock Titan
JATT II Acquisition Corp. (JATT) plans Talawar merger backed by $225M PIPE - Stock Titan
JATT II Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
VSCTF Stock Price and Chart — OTC:VSCTF - TradingView
COPL|Copley Acquisition Corp|Price:10.480|Chg%:+0.010 - TradingKey
JATT II Acquisition Corp Revenue Breakdown – NASDAQ:JATT - TradingView
FACT|FACT II Acquisition Corp|Price:10.660|Chg%:+0.010 - TradingKey
BBCQ|Bleichroeder Acquisition II Units|Price:10.170| - TradingKey
MACI|Melar Acquisition Corp I|Price:10.910|Chg%:+0.010 - TradingKey
ASPC|A SPAC III Acquisition Corp|Price:10.542|Chg%:-0.098 - TradingKey
SPEG|Silver Pegasus Acquisition Corp|Price:10.300| - TradingKey
WTG|Wintergreen Acquisition Corp|Price:10.490|Chg%:+0.020 - TradingKey
FSHP|Flag Ship Acquisition Corp|Price:11.110| - TradingKey
JATT|JATT II Acquisition Ord Shs|Price:13.290|Chg%:+1.080 - TradingKey
ENHA|A Paradise Acquisition Ord Shs Class A|Price:2.650|Chg%:+0.020 - TradingKey
Talawar Therapeutics Appoints Steve Migausky as Chief Legal and Administrative Officer - PR Newswire
Jatt Ventures Ii L.p. Net Worth (2026) - GuruFocus
Biotech-Focused Hedge Funds Back Talawar’s Fast Moving SPAC Merger - Institutional Investor
JATTJatt II Acquisition Corp Revenue Breakdown - Finviz
JATT II Acquisition (JATT) sponsor forfeits 225,000 shares after over-allotment expiry - Stock Titan
JATT II Acquisition Corp. (JATT) sponsor forfeits 225,000 Ordinary Shares - Stock Titan
Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases - AOL.com
Talawar Therapeutics to debut on Nasdaq with $285m as Dupixent challenger - Yahoo Finance
Price to book forward of JATT II Acquisition Corp – NASDAQ:JATT - TradingView
Talawar (NASDAQ: TLWR) to Merge with JATT II; $285M Expected - Stock Titan
Price to sales forward of JATT II Acquisition Corp – NASDAQ:JATT - TradingView
Price to earnings forward of JATT II Acquisition Corp – NASDAQ:JATT - TradingView
Talawar Therapeutics and JATT II Announce $285M Merger to Advance Bispecific Antibody for Atopic Dermatitis - Minichart
Talawar–JATT II deal includes $225M PIPE (NASDAQ: JATT) - Stock Titan
Biotech SPAC deal gets it to Nasdaq; AstraZeneca Phase 3 win in children's bone disease - Endpoints News
Talawar Tx launches as publicly traded biotech - The Pharma Letter
Enterprise value to revenue forward of JATT II Acquisition Corp – NASDAQ:JATT - TradingView
Enterprise value to EBIT forward of JATT II Acquisition Corp – NASDAQ:JATT - TradingView
JATT II Acquisition to Merge With Talawar Tx; JATT to Become Subsidiary in SPAC Deal - TradingView
Talawar, JATT II (Nasdaq: JATT) unveil $225M PIPE-backed biotech merger - Stock Titan
Talawar Therapeutics To Go Public Through A SPAC Deal With JATT II Acquisition - Pulse 2.0
JATT II Acquisition, Talawar Therapeutics announce combination agreement - TipRanks
Press Release: Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases - Moomoo
Talawar Tx Inc. entered into a definitive business combination agreement to acquire JATT II Acquisition Corp. from JATT Ventures II L.P. in a reverse merger transaction. - marketscreener.com
JATT II ACQUISITION CORP (JATT) Stock Chart - ChartMill
OCAC.U Stock Fund Price and Chart — BOATS:OCAC.U - TradingView
JATT Price Today: JATT II Acquisition Corp. Stock Price, Quote & Chart | MEXC - MEXC Exchange
BermudaAppleby Advises Amanat Acquisition In Its USD75M Initial Public Offering - Mondaq
JATT II Acquisition Corp 2026 Q1 SEC Filing: Financials, Management Discussion, and Regulatory Disclosures - Minichart
JATT II Acquisition Corp. 1Q 2026: Net income $(68,793), EPS $(0.05) — 10-Q Summary - TradingView
JATT II Acquisition Corp (NASDAQ: JATT) files 10-Q after $60M SPAC IPO - Stock Titan
Cayman IslandsAppleby Advises JATT II Acquisition Corp In Its USD60M Initial Public Offering - Mondaq
Oaktree’s OACC SPAC Looks Quiet. The October Deadline Is the Real Story - Bez Kabli
RESEARCH ALLIANCE CORPORATION III ANNOUNCES PRICING OF $75 MILLION INITIAL PUBLIC OFFERING - Yahoo Finance
Amanat Acquisition Corp Announces Pricing of $75 Million Initial Public Offering - Yahoo Finance
JATT II Acquisition Corp (JATT) Price To Free Cash Flow - Zacks Investment Research
GUACU|Berto Acquisition II Units (Proposed)|Price:10.065|Chg%:0.04 - TradingKey
JATT Acquisition (JATT) Stock Price, News & Analysis $JATT - MarketBeat
JATT Technical Analysis & Stock Price Forecast - Intellectia AI
Number of shareholders of JATT II Acquisition Corp – NASDAQ:JATT - TradingView
JATT II Acquisition Corp (JATT) Price To Cash Flow - Zacks Investment Research
JATT II Acquisition (JATT) Stock Analysis Report | Financials & Insights - Benzinga
OTAI_u|OTAI_u.NB|Price:10.074|Chg%:0.02 - TradingKey
BWIV|Blue Water Acquisition IV Redeemable Units|Price:9.905|Chg%:-0.02 - TradingKey
SAGU_u|SAGU_u.NB|Price:10.080|Chg%:-0.03 - TradingKey
JATT Stock Price, Quote & Chart | JATT II ACQUISITION CORP (NASDAQ:JATT) - ChartMill
0.77%
0.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):